Cleared Traditional

K170317 - Alinity i Total ß-hCG Reagent Kit

K170317 is an FDA 510(k) clearance for Alinity i Total ß-hCG Reagent Kit, manufactured by Abbott Laboratories. The device is a Class 2 Chemistry device with product code DHA cleared through the Traditional 510(k) pathway after a 264-day FDA review.

K170317 · Abbott Laboratories · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2017
Decision
264d
Days
Class 2
Risk

K170317 is an FDA 510(k) clearance for the Alinity i Total ß-hCG Reagent Kit, Alinity i System. Classified as System, Test, Human Chorionic Gonadotropin (product code DHA), Class II - Special Controls.

Submitted by Abbott Laboratories (Abbott Park, US). The FDA issued a Cleared decision on October 23, 2017 after a review of 264 days - an extended review cycle.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1155 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Abbott Laboratories devices

FDA 510(k) Submission Details - K170317

510(k) Number K170317 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 01, 2017
Decision Date October 23, 2017
Days to Decision 264 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
176d slower than avg
Panel avg: 88d · This submission: 264d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DHA Device Classification - Class 2, Special Controls

Product Code DHA System, Test, Human Chorionic Gonadotropin
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1155
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - DHA System, Test, Human Chorionic Gonadotropin

All 45
Devices cleared under the same product code (DHA) and FDA review panel - the closest regulatory comparables to K170317.
ADVIA Centaur® Total hCG assay
K200210 · Siemens Healthcare Diagnostics, Inc. · Jul 2021
MAGLUMI 2000 HCG/ß-HCG
K192547 · Shenzhen New Industries Biomedical Engineering Co., Ltd. · Jan 2020
Atellica IM Total hCG (ThCG)
K192790 · Siemens Healthcare Diagnostics, Inc. · Oct 2019
Diazyme DZ-Lite Total beta-hCG Test System
K163418 · Diazyme Laboratories · Aug 2017
ACCESS TOTAL BHCG (5TH IS)
K130020 · Beckman Coulter, Inc. · Oct 2013
LIAISON XL HCG
K131037 · DiaSorin, Inc. · Sep 2013